Lataa...
NOVEL IMMUNOTHERAPIES
Multiple myeloma is still a fatal disease. Despite advances in high-dose chemotherapy, stem cell transplantation, and the development of novel therapeutics, relapse of the underlying disease remains the primary cause of treatment failure. Strategies for post-transplantation immunomodulation are desi...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2862628/ https://ncbi.nlm.nih.gov/pubmed/20010170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e3181c51f0d |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|